|
|
|
|
| |
|
|
Despite Doubts, Cancer Therapy Draws Patients (Science/Technology, 6 articles)
|
For the thousands of British men each year who develop the most aggressive form of prostate cancer, the treatment options have generally been exhausted. Most will have had surgery and radiotherapy, as well as chemical castration, the drug therapy that stops them from producing the male hormones that prostate tumours need to grow. Should their cancers return, and they receive a diagnosis of castration-resistant prostate cancer (CRPC), there is little more that medicine can do. Like all cancers, prostate tumours owe their origins to a biological domino effect, and preliminary results have suggested that this drug can prevent a critical stage. Scientists are hailing a new drug to treat aggressive prostate cancer as potentially the most significant advance in the field for 70 years. Abiraterone could potentially treat up to 80% of patients with a deadly form of the disease resistant to currently available chemotherapy, they say. PUERTO VALLARTA, Mexico - Some weekends, more than a dozen American men wait at beachfront hotels, anxious for their turns in the treatment room at a small private hospital here. In 2008, the American Cancer Society estimates, 186,320 men will learn that they have it and 28,660 will die from it.
|
|
|
|
Facebook face-lift features expanded Wall (Science/Technology, 6 articles)
|
SAN FRANCISCO - Facebook Inc. is making sweeping changes to the world's largest social networking site, aiming to give users more control and to curb new forms of spam, company officials said late on Sunday. These profiles, which can be organized into tabbed pages, let users share tidbits of their lives with select groups of friends or colleagues. Not one exception? No. The young women in head scarves who patiently explain what can or cannot be done on Friday according to Islam? Absolutely.
|
| |
|
|
blaster@cs.columbia.edu
|
